Skip to main content
PRVA
NASDAQ Life Sciences

Privia Health Reaffirms FY26 Revenue Guidance at $2.35B-$2.45B

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$24.71
Mkt Cap
$3.014B
52W Low
$18.77
52W High
$26.51
52W Position info
32% above low
Off High info
6.8% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PRVA sits 32% above its 52-week low of $18.77.

Summary

Privia Health Group has reaffirmed its revenue guidance for fiscal year 2026, projecting a range of $2.35 billion to $2.45 billion. This guidance provides investors with a clear outlook on the company's expected financial performance for the upcoming year. While the term "backs" suggests a reiteration rather than a new forecast, specific revenue targets are crucial for financial modeling and assessing the company's growth trajectory. Traders will use this information to validate or adjust their valuation models and investment theses.

At the time of this announcement, PRVA was trading at $24.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3B. The 52-week trading range was $18.77 to $26.51. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PRVA - Latest Insights

PRVA
Nov 05, 2026, 8:50 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.19
Real-time Price: $24.55 info
Change: +$1.36 (+6%) info
Market Cap: $3.137B info
PRVA
Nov 05, 2026, 6:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.00
Real-time Price: $24.55 info
Change: +$2.55 (+12%) info
Market Cap: $3.137B info
PRVA
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.00
Real-time Price: $24.55 info
Change: +$2.55 (+12%) info
Market Cap: $3.137B info
PRVA
Nov 02, 2026, 8:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.48
Real-time Price: $24.55 info
Change: +$3.07 (+14%) info
Market Cap: $3.137B info
PRVA
Sep 08, 2026, 2:48 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $20.83
Real-time Price: $24.55 info
Change: +$3.72 (+18%) info
Market Cap: $3.137B info